Sponsored
Recent Updates
  • Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CROs Market, 2019-2030.”

    The report features a detailed study on the current landscape of contract service providers focused on regulatory affairs management for medical devices. The study features an in-depth analysis, highlighting the capabilities of the various CROs engaged in this domain, across different regions of the globe.
    For more information please click on the following link
    https://www.rootsanalysis.com/reports/view_document/med-dev-regulatory/282.html
    Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CROs Market, 2019-2030.” The report features a detailed study on the current landscape of contract service providers focused on regulatory affairs management for medical devices. The study features an in-depth analysis, highlighting the capabilities of the various CROs engaged in this domain, across different regions of the globe. For more information please click on the following link https://www.rootsanalysis.com/reports/view_document/med-dev-regulatory/282.html
    WWW.ROOTSANALYSIS.COM
    Contract Regulatory Affairs Management Market for Medical Devices, 2019-2030-Futuer Forecast | Indsutry Analysis | Market Size | 2030
    Driven by Rapidly growing Demand, the Contract Regulatory Affairs Market for Medical Device is anticipated to grow at an annualized rate of around 7% till 2030
    0 Comments 0 Shares
  • In the past few years, there has been a significant surge in the demand for recombinant proteins and cellular systems for biomedical research, diagnostics and different therapies. In order to support the large- scale production and manufacturing of such cell- based products, there is an imperative need for the efficient development of high- quality stable cell lines.

    To request a sample copy / brochure of this report, please visit : https://www.rootsanalysis.com/reports/cell-line-development-and-characterization-services/request-sample.html
    In the past few years, there has been a significant surge in the demand for recombinant proteins and cellular systems for biomedical research, diagnostics and different therapies. In order to support the large- scale production and manufacturing of such cell- based products, there is an imperative need for the efficient development of high- quality stable cell lines. To request a sample copy / brochure of this report, please visit : https://www.rootsanalysis.com/reports/cell-line-development-and-characterization-services/request-sample.html
    Request Sample - Cell Line Development and Characerization Services Market | Industry Analysis | Market Size | 2030
    The Cell Line Development and Characterization Services Market, 2020-2030 report features an extensive study on the current market landscape...
    0 Comments 0 Shares
  • Roots Analysis has announced the addition of “CAR-T Cell Therapy Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Hepatocellular Carcinoma and Others), Target Antigens– Industry Trends and Global Forecasts, 2021-2030” report to its list of offerings.
    To order this 795+ page report, which features 165+ figures and 270+ tables, please visit https://www.rootsanalysis.com/reports/view_document/car-t-therapies-market/269.html
    Roots Analysis has announced the addition of “CAR-T Cell Therapy Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Hepatocellular Carcinoma and Others), Target Antigens– Industry Trends and Global Forecasts, 2021-2030” report to its list of offerings. To order this 795+ page report, which features 165+ figures and 270+ tables, please visit https://www.rootsanalysis.com/reports/view_document/car-t-therapies-market/269.html
    WWW.ROOTSANALYSIS.COM
    CAR-T Therapies Market (3rd Edition) | Industry Analysis | Market Size | 2030
    CAR-T Therapies market report features an extensive study of the current market landscape and future potential of the industry players
    0 Comments 0 Shares
  • Roots Analysis has announced the addition of the (Avastin) Bevacizumab Biosimilars – Pipeline Review and Partnerships” report to its list of offerings.

    Biosimilars of bevacizumab are currently approved / being developed to treat colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, renal cell carcinoma, and cervical cancer. Considering that several enemy products are already in the market, and several others are under development, the bevacizumab biosimilar market is anticipated to witness noteworthy growth in the foreseen future.

    For additional details, please visit
    https://www.rootsanalysis.com/reports/avastin-biosimilars-pipeline-review-and-partnerships.html
    Roots Analysis has announced the addition of the (Avastin) Bevacizumab Biosimilars – Pipeline Review and Partnerships” report to its list of offerings. Biosimilars of bevacizumab are currently approved / being developed to treat colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, renal cell carcinoma, and cervical cancer. Considering that several enemy products are already in the market, and several others are under development, the bevacizumab biosimilar market is anticipated to witness noteworthy growth in the foreseen future. For additional details, please visit https://www.rootsanalysis.com/reports/avastin-biosimilars-pipeline-review-and-partnerships.html
    WWW.ROOTSANALYSIS.COM
    Avastin® (Bevacizumab) Biosimilars - Pipeline Review and Partnerships
    AvastinR (Bevacizumab) Biosimilars - Pipeline Review and Partnerships report features an extensive study of the current market landscape and future potential...
    0 Comments 0 Shares
  • Roots Analysis has announced the addition of “Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030” report to its list of offerings.

    The development of such biologics is inherently complex, and many drug developers are now seeking to optimize R&D efficiency and affiliated costs

    To order this 450+ page report, which features 120+ figures and 140+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/antibody-discovery-services-and-platforms/213.html
    Roots Analysis has announced the addition of “Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030” report to its list of offerings. The development of such biologics is inherently complex, and many drug developers are now seeking to optimize R&D efficiency and affiliated costs To order this 450+ page report, which features 120+ figures and 140+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/antibody-discovery-services-and-platforms/213.html
    WWW.ROOTSANALYSIS.COM
    Antibody Discovery: Services and Platforms Market (4rd Edition) | Industry Analysis | Market Size | 2030
    We anticipate the antibody discovery services and platforms market to grow at an annualized rate of over 23% in the coming decade; the opportunity is likely to be well-distributed across geographies
    0 Comments 0 Shares
  • Roots Analysis has announced the addition of “Handheld Imaging Devices Market, 2020-2030” report to its list of offerings.

    According to industry experts, handheld imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability. Further, these devices have proven to be useful in quarantining patients demonstrating symptoms of pleural wall thickening and lung congestion, a characteristic of pneumonia, as well as observed in patients suffering from the novel coronavirus (COVID-19).

    To order this 235+ page report, which features 95+ figures and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html
    Roots Analysis has announced the addition of “Handheld Imaging Devices Market, 2020-2030” report to its list of offerings. According to industry experts, handheld imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability. Further, these devices have proven to be useful in quarantining patients demonstrating symptoms of pleural wall thickening and lung congestion, a characteristic of pneumonia, as well as observed in patients suffering from the novel coronavirus (COVID-19). To order this 235+ page report, which features 95+ figures and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html
    WWW.ROOTSANALYSIS.COM
    Handheld Ultrasound Imaging Devices | Industry Analysis | Market Size | 2030
    With enhanced demand for point-of-care imaging solution, the handheld ultrasound imaging devices market is estimated to reach USD 1.2 billion by 2030
    0 Comments 0 Shares
  • Roots Analysis has announced the addition of the “HUMIRA® (Adalimumab) Biosimilars – Pipeline Review and Partnerships” report to its list of offerings.

    Detailed review of the adalimumab biosimilars pipeline and affiliated developer landscape, featuring a list of involved innovator companies and their respective therapy candidates. It includes insights based on the current status of biosimilar candidates, and important developer related details (including headquarters, and type of developer).

    For additional details, please visit
    https://www.rootsanalysis.com/reports/humira-biosimilars-pipeline-review-and-partnerships.html
    Roots Analysis has announced the addition of the “HUMIRA® (Adalimumab) Biosimilars – Pipeline Review and Partnerships” report to its list of offerings. Detailed review of the adalimumab biosimilars pipeline and affiliated developer landscape, featuring a list of involved innovator companies and their respective therapy candidates. It includes insights based on the current status of biosimilar candidates, and important developer related details (including headquarters, and type of developer). For additional details, please visit https://www.rootsanalysis.com/reports/humira-biosimilars-pipeline-review-and-partnerships.html
    WWW.ROOTSANALYSIS.COM
    HUMIRA®1 (Adalimumab) Biosimilars - Pipeline Review and Partnerships
    HUMIRAR (Adalimumab) Biosimilars - Pipeline Review and Partnerships report features an extensive study of the current market landscape and future potential...
    0 Comments 0 Shares
  • Roots Analysis has announced the addition of “Home Blood Collection Devices market, 2021-2030” report to its list of offerings.

    The inherent challenges associated with collection of blood samples at lab, such as use of invasive methods, high cost and time intensive nature of the process, have paved the way for the adoption of at-home blood collection and micro sampling devices. These devices are now being adopted by various CROs and diagnostic labs located across the globe owing to their various advantages.

    To request a sample copy / brochure of this report, please visit
    https://www.rootsanalysis.com/reports/at-home-blood-collection-and-microsampling-devices-market.html

    Roots Analysis has announced the addition of “Home Blood Collection Devices market, 2021-2030” report to its list of offerings. The inherent challenges associated with collection of blood samples at lab, such as use of invasive methods, high cost and time intensive nature of the process, have paved the way for the adoption of at-home blood collection and micro sampling devices. These devices are now being adopted by various CROs and diagnostic labs located across the globe owing to their various advantages. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/at-home-blood-collection-and-microsampling-devices-market.html
    WWW.ROOTSANALYSIS.COM
    At-Home Blood Collection and Micro Sampling Devices Market | Industry Analysis | Market Size | 2030
    At-Home Blood Collection and Micro Sampling Devices Market report features an extensive study of the current market...
    0 Comments 0 Shares
  • In the past few years, there has been a significant surge in the demand for recombinant proteins and cellular systems for biomedical research, diagnostics and different therapies. In order to support the large- scale production and manufacturing of such cell- based products, there is an imperative need for the efficient development of high- quality stable cell lines. In fact, 60-70% of manufacturing processes of available biologics require live mammalian systems.

    To request a sample copy / brochure of this report, please visit : https://www.rootsanalysis.com/reports/cell-line-development-and-characterization-services/request-sample.html
    In the past few years, there has been a significant surge in the demand for recombinant proteins and cellular systems for biomedical research, diagnostics and different therapies. In order to support the large- scale production and manufacturing of such cell- based products, there is an imperative need for the efficient development of high- quality stable cell lines. In fact, 60-70% of manufacturing processes of available biologics require live mammalian systems. To request a sample copy / brochure of this report, please visit : https://www.rootsanalysis.com/reports/cell-line-development-and-characterization-services/request-sample.html
    Request Sample - Cell Line Development and Characerization Services Market | Industry Analysis | Market Size | 2030
    The Cell Line Development and Characterization Services Market, 2020-2030 report features an extensive study on the current market landscape...
    0 Comments 0 Shares
  • Roots Analysis has announced the addition of “Pharmaceutical Secondary Packaging Market” report to its list of offerings.

    The anticipated growth in the therapeutics pipeline is likely to translate into a significant rise in the demand for cost-effective and quality secondary packaging solutions, presenting lucrative opportunities for contract packaging organizations. Driven by the growth of the overall pharmaceutical industry and increasing preference of drug developers for outsourcing certain operations, the secondary packaging providers market is expected to witness a steady increase.

    To order this 210+ page report, which features 130+ figures and 160+ tables, please visit
    https://www.rootsanalysis.com/reports/pharmaceutical-secondary-packaging-market.html
    Roots Analysis has announced the addition of “Pharmaceutical Secondary Packaging Market” report to its list of offerings. The anticipated growth in the therapeutics pipeline is likely to translate into a significant rise in the demand for cost-effective and quality secondary packaging solutions, presenting lucrative opportunities for contract packaging organizations. Driven by the growth of the overall pharmaceutical industry and increasing preference of drug developers for outsourcing certain operations, the secondary packaging providers market is expected to witness a steady increase. To order this 210+ page report, which features 130+ figures and 160+ tables, please visit https://www.rootsanalysis.com/reports/pharmaceutical-secondary-packaging-market.html
    WWW.ROOTSANALYSIS.COM
    Pharmaceutical Secondary Packaging Market | Industry Analysis | Market Size | 2035
    Market research report on Pharmaceutical Secondary Packaging Market; with a focus on current landscape, key players and future growth opportunities
    0 Comments 0 Shares
More Stories